Is extended and saturation biopsy necessary?: Review article

International Journal of Urology

Volumn 17, Issue 5, 2010, Pages 432-447

  Scattoni, Vincenzo ^a   MacCagnano, Carmen ^a   Zanni, Giuseppe ^a   Angiolilli, Diego ^a   Raber, Marco ^a   Roscigno, Marco ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Diagnosis transrectal ultrasound; Prostate biopsy; Prostatic neoplasms

Indexed keywords

ANESTHETIC AGENT; ANTROLIN; CODEINE; DICLOFENAC; EMLA; LIDOCAINE; LUBRICATING AGENT; PARACETAMOL; PETHIDINE; PLACEBO; PRILOCAINE; PROSTATE SPECIFIC ANTIGEN; ROPIVACAINE; UNCLASSIFIED DRUG;

ANALGESIA; BLOOD FLOW; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DECISION MAKING; DIAGNOSTIC APPROACH ROUTE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; ELASTOGRAPHY; EXPERIENCE; HUMAN; IMAGING; LOCAL ANESTHESIA; NERVE BLOCK; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REPEAT PROCEDURE; REVIEW; SEMINAL VESICLE; SENSITIVITY AND SPECIFICITY; TISSUE DOPPLER IMAGING; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT INDICATION;

BIOPSY; HUMANS; MALE; PROSTATIC NEOPLASMS; UNNECESSARY PROCEDURES;

EID: 77951278120     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02479.x     Document Type: Review

References (133)

1. Astraldi A. Diagnosis of cancer of the prostate: biopsy by rectal route. Urol. Cutan Rev. 1937 41 : 421.
2. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided trans-rectal core biopsies of the prostate. J. Urol. 1989 142 : 71 4, discussion 74-5.
3. Scattoni V, Zlotta S, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur. Urol. 2007 52 : 1309 1322.
4. Shariat SF, Roehrborn CG. Using biopsy to detect prostate cancer. Rev. Urol. 2008 10 : 262 279.
5. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J. Urol. 2001 166 : 86 91, discussion 92.
6. Borboroglu PG, Corner SW, Riffenburgh RH, Amling CL. Extensive repeat trans-rectal ultrasound guided prostate biopsy in patient with previous benign sextant biopsies. J. Urol. 2000 163 : 158 162.
7. Bertaccini A, Fandella A, Prayer-Galetti T et al. Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project. Anticancer Res. 2007 27 : 659 666.
8. Yurdakul T, Taspinar B, Kilic O, Kilinc M, Serarslan A. Topical and long-acting local anesthetic for prostate biopsy: a prospective randomized placebo-controlled study. Urol. Int. 2009 83 : 151 154.
9. Ingber MS, Ibrahim I, Turzewski C, Hollander JB, Diokno AC. Does periprostatic block reduce pain during transrectal prostate biopsy? A randomized, placebo-controlled, double-blinded study. Int. Urol. Nephrol. 2009. Published on line 8 Aug 2009. DOI 10.1007/s11255-009-9621-2.
10. Montoliu García A, Juan Escudero J, Ramos de Campos M et al. Prospective randomized study on the use of lidocaine local anesthesia in prostate biopsy. Arch. Esp. Urol. 2009 62 : 339 347.
11. Bingqian L, Peihuan L, Yudong W et al. Intraprostatic local anesthesia with periprostatic nerve block for transrectal ultrasound guided prostate biopsy. J. Urol. 2009 182 : 479 483, discussion 483-4.
12. Luján Marco S, Bango García V Arlandis Guzmán S et al. Comparative study between analgesic efficacy and safety of meperidine compared with lidocaine periprostatic infiltration in transrectal ultrasound guided prostate biopsy. Actas Urol. Esp. 2009 33 : 30 4.
13. Skriapas K, Konstandinidis C, Samarinas M et al. Pain level and anal discomfort during transrectal ultrasound for guided prostate biopsy. Does intrarectal administration of local anesthetic before periprostatic anesthesia makes any difference? Minerva Urol. Nephrol. 2009 61 : 137 142.
14. Visapää H, Taari K. Combination of paracetamol, codeine and lidocaine for pain relief during transrectal ultrasound guided biopsy of the prostate. Scand. J. Surg. 2009 98 : 55 7.
15. Kandirali E, Ulukaradag E, Uysal B et al. Is only perianal anesthesia with lidocaine-prilocaine cream sufficient to decrease the pain during transrectal ultrasound-guided prostate biopsy? A prospective randomized study. Urol. Int. 2009 82 : 262 265.
16. Giannarini G, Autorino R, Valent F et al. Combination of perianal-intrarectal lidocaine-prilocaine cream and periprostatic nerve block for pain control during transrectal ultrasound guided prostate biopsy: a randomized, controlled trial. J. Urol. 2009 181 : 585 591, discussion 591-3.
17. Cantiello F, Imperatore V, Iannuzzo M et al. Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. BJU Int. 2009 103 : 1195 1198.
18. Akan H, Yildiz O, Dalva I, Yücesoy C. Comparison of two periprostatic nerve blockade techniques for transrectal ultrasound-guided prostate biopsy: bilateral basal injection and single apical injection. Urology 2009 73 : 23 6.
19. Cam K, Sener M, Kayikci A, Akman Y, Erol A. Combined periprostatic and intraprostatic local anesthesia for prostate biopsy: a double-blind, placebo controlled, randomized trial. J. Urol. 2008 180 : 141 144, discussion 144-5.
20. Szlauer R, Gotschl R, Gnad A et al. Comparison of lidocaine suppositories and periprostatic nerve block during transrectal prostate biopsy. Urol. Int. 2008 80 : 253 256.
21. Bhomi KK, Lim HH, Consigliere DT, Tiong HY. Control of pain during transrectal ultrasound-guided prostate biopsy: a prospective study comparing two methods. Urol. Int. 2007 79 : 332 335.
22. Inal G, Adsan O, Ugurlu O et al. Comparison of four different anesthesia methods for relief of all pain during transrectal ultrasound-guided prostate biopsy. Int. Urol. Nephrol. 2008 40 : 335 339.
23. Raber M, Scattoni V, Roscigno M et al. Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial. Eur. Urol. 2008 53 : 967 973.
24. Ashley RA, Inman BA, Routh JC et al. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer 2007 110 : 1708 1714.
25. Lee HY, Lee HJ, Byun SS. Effect of intraprostatic local anesthesia during transrectal ultrasound guided prostate biopsy: comparison of 3 methods in a randomized, double-blind, placebo controlled trial. J. Urol. 2007 178 : 469 472.
26. Naughton CK, Ornstein DK, Smith DS et al. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomised trial of 6 versus 12 cores. J. Urol. 2000 163 : 168 171.
27. Chang SC, Alberts G, Wells N et al. Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective randomized trial. J. Urol. 2001 166 : 2178 2180.
28. Nash PA, Bruce JE, Indudhara R et al. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J. Urol. 1996 155 : 607 609.
29. Hollabaugh RS, Smochowski AR, Steiner MS et al. Neuroanatomy of the male rabdmiosphincter. Urology 1997 49 : 426.
30. Desgrandchamps F, Meria P, Irani J et al. The rectal administration of lidocaine gel and tolerance of transrectak ultrasonography-guided biopsy of the prostate: a prospective randomised placebo-controlled study. BJU Int. 1999 83 : 1007 1009.
31. Issa MM, Bux S, Chun T et al. A randomised prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy : the Emory University experience. J. Urol. 2000 164 : 397 399.
32. Lynn NN, Collins GN, Brown SC et al. Periprostatic nerve block gives better analgesia for prostatic biopsy. BJU Int. 2002 90 : 424 426.
33. Matlaga BR, Lovato JF, Hall MC. Randomized prospective trial of a novel local anaesthetic technique for extensive prosate biopsy. Urology 2003 61 : 972 976.
34. Adamakis I, Mitropoulos D, Haritopoulos K et al. Pain during transrectal ultrasonography guided biopsy : a randomised prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocaine cream. World J. Urol. 2004 22 : 281 284.
35. Alawi AS, Soloway MS, Vaidya A et al. Local anesthesia for ultrasound guided prostate biopsy: a prospective randomised trial comparing 2 methods. J. Urol. 2001 166 : 1343 1345.
36. Stirling BN, Shockley KF, Carothers GG et al. Comparison of local anesthesia techinique during transrectal ultrasound guided biopsy. Urology 2002 60 : 89 92.
37. Tiong HY, Liew LC, Samuel M, Consigliere D, Esuvaranathan K. A meta analysis of local anaesthesia for transrectal ultrasound guided biopsy of the prostate. Prostate Cancer Prostatic Dis. 2007 10 : 127 136.
38. Ragavan N, Philip J, Balasubramanian SP et al. A randomized, controlled trial comparing lidocaine periprostatic nerve block, diclofenac suppository and both for transrectal ultrasound guided biopsy of the prostate. J. Urol. 2005 174 : 510 513.
39. Moinzadeh A, Mourtizinos A, Triaca V, Hamawy KJ. A randomised double blind prospective study evaluating patient tolerance of transrectal ultrasound-guided biopsy of the prostate using prebiopsy rofecoxib. Urology 2003 62 : 1054 1057.
40. Hirsh I, Kaploun A, Faris G et al. Tramadol improves patients' tolerance of transrectal ultrasound-guided biopsy of the prostate. Urology 2007 69 : 491 494.
41. Pendleton J, Costa J, Wludyka P et al. Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the prostate: a prospective randomised, controlled trial. J. Urol. 2006 176 : 1372.
42. Visapää H, Taari K. Combination of paracetamol, codeine and lidocaine for pain relief during transrectal ultrasound guided biopsy of the prostate. Scand. J. Surg. 2009 98 : 55 7.
43. Eichler K, Hempel S, Wilby J et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J. Urol. 2006 175 : 1605 1612.
44. Descazeaud A, Rubin M, Chemama S et al. Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen. World J. Urol. 2006 24 : 676 680.
45. Delongchamps NB, de la Roza G, Jones R, Jumbelic M, Haas GP. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int. 2009 103 : 49 54.
46. Scattoni V, Roscigno M, Raber M et al. Initial extended transrectal prostate biopsy - are more prostate cancers detected with 18 cores than with 12 cores? J. Urol. 2008 179 : 1327 1331.
47. Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int. 2007 99 : 1340 1344.
48. Naughton CK, Miller DC, Mager DE, Ornsetin DK, Catalona WJ. A prospective randomised trial comparing 6 versus 12 prostate biopsy cores: impact of cancer detection. J. Urol. 2000 164 : 388.
49. Gore JL, Shariat S, Miles BJ et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J. Urol. 2001 165 : 1554 1559.
50. Siu W, Dunn RL, Shah RB et al. Use of extended pattern technique for initial prostate biopsy. J. Urol. 2005 174 : 505 509.
51. Singh H, Canto EI, Shariat SF et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J. Urol. 2004 171 : 1089 1092.
52. de la Taille A, Antiphon P, Salomon L et al. prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003 61 : 1181 1186.
53. Presti JC Jr., O'Dowd GJ, Miller MC et al. Extended peripheral zone biopsy schemes increases cancer detection rates and minimizes variance in prostate specific antigen and age related cancer rates : results of a community multi-practice study. J. Urol. 2003 169 : 125 129.
54. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol. 2000 164 : 393 396.
55. Meng MV, Franks JH, Presti JC Jr., Shinohara K. The utility of apical anterior horn biopsies in prostate cancer detection. Urol. Oncol. 2003 21 : 361 365.
56. Patel AR, Jones JS, Rabets J, DeOreo G, Zippe CD. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004 63 : 87 9.
57. Philip J, Hanchanale V, Foster CS, Javle P. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocol. BJU Int. 2006 98 : 559 562.
58. Pelzer AE, Bektic J, Berger AP et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol screening project. Eur. Urol. 2005 48 : 916 921.
59. Peyromaure M, Ravery V, Boccon-Gibod L. The role of the biopsy of the transitional zone and of the seminal vesicles in the diagnosis and staging of prostate cancer. Eur. Urol. Suppl. 2002 1 : 40 6.
60. Onur E, Littrup PJ, Pontes JE, Bianco FJ Jr. Contemporary impact of trans-rectal ultrasound lesions for prostate cancer detection. J. Urol. 2004 172 : 512 514.
61. Djavan B. Prostate biopsies and Vienna Nomograms. Eur. Urol. Suppl. 2006 5 : 500 510.
62. Ficarra V, Novella G, Novara G et al. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy. Eur. Urol. 2005 48 : 932 937.
63. Inahara M, Suzuki H, Kojima S et al. Improved prostate cancer detection using systematic 14-core biopsy for lager prostate glands with normal digital rectal examination finding. Urology 2006 68 : 815 819.
64. Damiano R, Autorino R, Perdona S et al. Are extended biopsies really necessary to improve prostate cancer detection? Prostate Cancer Prostatic Dis. 2003 6 : 250 255.
65. Jones SJ, Patel A, Schoenfield L et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. Urol. 2006 175 : 485 488.
66. de La Rosette JMCH, Wink MH, Mamoulakis C et al. Optimizing prostate cancer detection : 8 versus 12 core biopsy protocol. J. Urol. 2009 182 : 1329 1336.
67. Lane BR, Zippe CD, Abouassaly A, Schoenfield L, Magi-Galluzzi C, Stephen Jones L. Saturation Tecnique does not decrease cancer detection during follow-up after initial prostate biopsy. J. Urol. 2008 179 : 1749 1750.
68. Guichard G, Larre S, Gallina A et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutives patients. Eur. Urol. 2007 52 : 430 435.
69. Scattoni V, Raber M, Abdollah F et al. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Eur. Urol. 2009 57 : 1 8.
70. Patel AR, Jones JS. Optimal biopsy strategies for the diagnosis and staging of prostate cancer. Curr. Opin. Urol. 2009 19 : 232 237.
71. Presti JC Jr. Repeat biopsy-when, where and how. Urol. Oncol. 2009 27 : 312 314.
72. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J. Urol. 1995 153 : 1496 1498.
73. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol. 1994 151 : 1571 1574.
74. Fleshner N, Klotz L. Role of 'saturation biopsy' in the detection of prostate cancer among difficult diagnostic cases. Urology 2002 60 : 93 7.
75. Pryor MB, Schellhammer PF. The pursuit of prostate cancer in patients with a rising prostate specific antigen and multiple negative transrectal ultrasound guided prostate biopsies. Clin. Prostate Cancer 2002 1 : 172 176.
76. Walz J, Graefen M, Chun FK et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur. Urol. 2006 50 : 498 505.
77. Rabets JC, Jones JS, Patel A et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J. Urol. 2004 172 : 94 7.
78. Epstein JI, Sanderson H, Carter HB et al. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 2005 66 : 356 360.
79. Warlick C, Trock BJ, Landis B et al. Delayed versus immediate surgical intervention and prostate cancer outcome. J. Natl. Cancer Inst. 2006 98 : 355 357.
80. Abouassaly R, Lane BR, Stephen Jones J. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 2008 71 : 573 577.
81. Boccon-Gibod LM, de Longchamps NB, Toublanc M et al. Prostate saturation biopsy in the re-evaluation of microfocal prostate cancer. J. Urol. 2006 176 : 971 973.
82. Simon J, Kuefer R, Bartsch G Jr. et al. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int. 2008 102 : 459 462.
83. Epstein JI, Chan DW, Sokoll LJ. Non palpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J. Urol. 1998 160 : 2407 2411.
84. Cooperberg MR, Lubeck DP, Meng MV et al. The changing face of low risk prostate cancer: trends in clinical presentation and primary management. J. Clin. Oncol. 2004 22 : 2141 2149.
85. Master VA, Chi T, Simko JP et al. The independent impact of extended pattern biopsy on prostate cancer stage migration. J. Urol. 2005 174 : 1789 1793, discussion 1793.
86. Kahl P, Wolf S, Adam A et al. Saturation biopsy improves preoperative Gleason scoring of prostate cancer. Pathol. Res. Pract. 2009 205 : 259 264.
87. Kaufman JJ, Roenthal M, Godwin WE. Methods of diagnosis of carcinoma of the prostate: a comparison of clinical impression, prostate smear, needle biopsy open perineal biopsy and transurethral biopsy. J. Urol. 1954 72 : 450 463.
88. Ritkin MD, Kurtz AB, Goldberg BB. Sonographically guided transperineal prostate biopsy: preliminary experience with a longitudinal linear array transducer. AJR Am. J. Roentgenol. 1983 140 : 745 747.
89. Shandera KC, Thibault GP, Deshon JE et al. Variability in patient preparation for prostate biopsy among American Urologists. Urology 1998 52 : 644 646.
90. Emiliozzi P, Corsetti A, Tassi B et al. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six core prostate biopsy. Urology 2003 61 : 961 966.
91. Watanabe M, Hayashi T, Tsushima T et al. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int. J. Urol. 2005 12 : 969 963.
92. Kawakami S, Okuno T, Yonese J et al. Optimal sampling sites for repeat prostate biopsy: a recursive portioning analysis of three-dimensional 26-core systematic biopsy. Eur. Urol. 2007 51 : 675 683.
93. Emiliozzi P, Maymone S, Paterno A et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J. Urol. 2004 172 (6 Pt 1 2224 2226.
94. Takenaka A, Hara R, Hyodo Y et al. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores. Int. J. Urol. 2006 13 : 10 14.
95. Li H, Yan W, Zhou Y et al. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. Urology 2007 70 : 1157 1161.
96. Furuno T, Demura T, Kaneta T et al. Difference of cancer core distribution between first and repeat biopsy in patient diagnose by extensive transperineal ultrasound guided template prostate biopsy. Prostate 2004 58 : 76 81.
97. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993 186 : 509 513.
98. Kelly IM, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993 189 : 153 156.
99. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995 195 : 86 90.
100. Littrup PJ, Klein RM, Gross ML et al. Color Doppler of the prostate: histologic and racial correlations. Radiology 1995 197 : 365.
101. Ismail M, Petersen RO, Alexander AA et al. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease- free survival. Urology 1997 50 : 906 912.
102. Ismail M, Gomella LG, Alexander AA. Color Doppler sonography of the prostate. Tech. Urol. 1997 3 : 140 146.
103. Alexander AA. To color Doppler image the prostate or not: that is the question. Radiology 1995 195 : 11 13.
104. Rifkin MD, Alexander AA, Helinek TG, Merton DA. Color Doppler as an adjunct to prostate ultrasound. Scand. J. Urol. Nephrol. Suppl. 1991 137 : 85 9.
105. Pallwein L, Mitterberger M, Gradl J. Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr. Opin. Urol. 2007 17 : 39 47. (Pubitemid 44901089)
106. Amiel GE, Slawin KM. Newer modalities of ultrasound imaging and treatment of the prostate. Urol. Clin. North Am. 2006 33 : 329 337.
107. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am. J. Roetntgenol. 2000 174 : 623 627.
108. Remzi M, Dobrovits M, Reissigl A et al. European Society for Oncological Urology (ESOU). Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat biopsy? Eur. Urol. 2004 46 : 451 456.
109. Frauscher E, Helweg G, Gotwald TF et al. The value of contrast-enhanced color Doppler ultrasonography in the diagnosis of prostate cancer. Radiology 1998 209 : 417, abstract.
110. Bogers HA, Sedelaar JP, Beerlage HP et al. Contrast enhanced three dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999 54 : 97 104.
111. Unal D, Sedelaar JP, Aarnink RG et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int. 2000 86 : 58 64.
112. Albrecht T, Hoffmann CW, Schettler S et al. B-mode enhancement at phase inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000 216 : 273 278.
113. Halpern EJ, Verkh L, Forsberg F et al. Initial experience with contrast enhanced sonography of the prostate. AJR Am. J. Roentgenol. 2000 174 : 1575 1580.
114. Halpern EJ, Rosenberg M, Gomolla LG. Contrast enhanced sonography of the prostate. Radiology 2001 219 : 219 225.
115. Halpern EJ, Ramey JR, Strup SE et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005 104 : 2373 2383.
116. Ophir J, Cespedes I, Ponnekanti H et al. Elastography: a quantitative method for imaging the elasticity of biological tissue. Ultrason. Imaging 1991 13 : 111 134.
117. Pallwein L, Aigner F, Faschingbauer R et al. Prostate cancer diagnosis: value of real-time elastography. Abdom. Imaging 2008 33 : 729 735.
118. Konig K, Scheipers U, Pesavento A et al. Initial experiences with real-time elastography guided biopsies of the prostate. J. Urol. 2005 174 : 115 117.
119. Pallwein L, Mitterberger M, Pinggera G et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur. J. Radiol. 2008 65 : 304 310. Epub 2007 May 23.
120. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J. Urol. 2003 169 : 136 140.
121. Mian BM, Lehr DJ, Moore CK et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 2006 67 : 379 383.
122. Numao N, Kawakami S, Yonese J et al. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy. Int. J. Urol. 2008 15 : 1061 1066.
123. Davis JW, Kim J, Ward JF et al. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int. 2009. Published on line 3 Nov 2009; doi:10.1111/j.1464-410X.2009. 08964.x.
124. Moussa AS, Kattan MW, Berglund R, Yu C, Fareed K, Jones JS. A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling. BJU Int. 2009 105 : 352 358.
125. Babaain RJ, Troncoso P, Bhadkamkar DA, Johston DA. Analysis of clinico-pathologic factors predicting outcome after radical prostatectomy. Cancer 2001 91 : 1414 1422.
126. Mian BM, Naya Y, Okihara F et al. Role of the prostate biopsy schemes in accurate prediction of Gleason score. Urology 2006 67 : 379 383.
127. Stamey TA, Caldwell M, McNeal JE. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J. Urol. 2004 172 : 1297 1301.
128. Thickman D, Speers WC, Philpott PJ, Shapiro H. effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J. Urol. 1996 156 : 110 113.
129. Fugakai T, Namiki T, Namiki H et al. Discrepancies between Gleason score of needle biopsy and radical prostatetcomy specimes. Pathol. Int. 2001 51 : 364 370.
130. Cecchi R, Minervini R, Sepich CA et al. Correlation between Gleason score of needle biopsy and radical prostatectomy tissue. Int. Urol. Nephrol. 1998 30 : 575 580.
131. Epstein JI, Walsh PC, Sauvageot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J. Urol. 1997 158 : 1886 1890.
132. Divrik RT, Eroglu A, Sahin A et al. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol. Oncol. 2007 25 : 376 382.
133. Pepe P, Galia A, Fraggetta F et al. Prediction by quantitative histology on pathological stage in prostate cancer. Eur. J. Surg. Oncol. 2005 31 : 309 313.